GSI 62L Pill - beige capsule/oblong, 21mm
Generic Name: lenacapavir
Pill with imprint GSI 62L is Beige, Capsule/Oblong and has been identified as Sunlenca 300 mg. It is supplied by Gilead Sciences, Inc.
Sunlenca is used in the treatment of HIV Infection and belongs to the drug class miscellaneous antivirals. Sunlenca 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 62L
Sunlenca
- Generic Name
- lenacapavir
- Imprint
- GSI 62L
- Strength
- 300 mg
- Color
- Beige
- Size
- 21.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antivirals
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-3001
More about Sunlenca (lenacapavir)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antivirals
- Breastfeeding
- En español
Patient resources
- Sunlenca drug information
- Sunlenca oral/injection
- Sunlenca (Lenacapavir Oral) (Advanced Reading)
- Sunlenca (Lenacapavir Subcutaneous) (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
